Affordable, quality health care. For everyone.

Drug Therapy and Aging: Testimony Before the Full Committee of the House Committee on Ways and Means

Downloads

Mr. Chairman and distinguished members of the House Ways and Means Committee. My name is Bruce Stuart. I am a Professor at the University of Maryland School of Pharmacy. I also direct the Peter Lamy Center on Drug Therapy and Aging which conducts research on Medicare beneficiaries' drug coverage, utilization, and outcomes. I am pleased to be here this morning to address what I believe should be the core question underlying the debate over a Medicare drug benefit; namely, what will happen to beneficiaries if Congress fails to act? I will show that recent trends in coverage put future beneficiaries at risk of having significantly reduced options for meaningful prescription benefits if legislative action is not taken soon.

Publication Details

Publication Date: April 1, 2003
Citation:

Drug Therapy and Aging, Testimony Before the Full Committee of the House Committee on Ways and Means, Bruce Stuart, Ph.D., The Commonwealth Fund, April 9, 2003

Topics

Experts

Professor of Drug Therapy and Aging, University of Maryland